Abciximab en es it fr

Abciximab Brand names, Abciximab Analogs

Abciximab Brand Names Mixture

  • No information avaliable

Abciximab Chemical_Formula


Abciximab RX_link

Abciximab fda sheet

Abciximab FDA

Abciximab msds (material safety sheet)

Abciximab Synthesis Reference

(sequence listed in Kohmura C, Gold HK, Yasuda T, Holt R, Nedelman MA, Guerrero JL, Weisman HF, Collen D. A chimeric murine/human antibody Fab fragment directed against the platelet GPIIb/IIIa receptor enhances and sustains arterial thrombolysis with recombinant tissue-type plasminogen activator in baboons.Arterioscler Thromb. 1993 Dec;13(12):1837-42.) patent EP418316

Abciximab Molecular Weight


Abciximab Melting Point

61 oC (FAB fragment), 71 oC (whole mAb) - Vermeer, A.W.P. & Norde, W., Biophys. J. 78:394-404 (2000).

Abciximab H2O Solubility

No information avaliable

Abciximab State


Abciximab LogP


Abciximab Dosage Forms

Solution (IV Infusion)

Abciximab Indication

For treatment of myocardial infarction, adjunct to percutaneous coronory intervention, unstable angina

Abciximab Pharmacology

Used for the treatment of myocardial infarction and the prevention of platelet aggregation. Abciximab inhibits platelet aggregation by preventing the binding of fibrinogen, von Willebrand factor, and other adhesive molecules to GPIIb/IIIa receptor sites on activated platelets.

Abciximab Absorption

No information avaliable

Abciximab side effects and Toxicity

No information avaliable

Abciximab Patient Information

No information avaliable

Abciximab Organisms Affected

Humans and other mammals